Special Issue "Pharmacy Paediatrics"
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (30 November 2015)
Prof. Dr. Sandra Benavides, Pharm.D., FCCP, FPPAG
Professor and Assistant Dean for Accreditation and Programmatic Assessment College of Pharmacy, Larkin Health Sciences Institute 18301 N. Miami Avenue Miami, FL 33169.
Phone: +1 954 262 1372
Fax: +1 954 262 2278
Interests: pediatrics, obesity, metabolic syndrome, education
Dr. Richard Parrish, BSPharm, PhD, FCCP, BCPS
Chief Pharmacist and Director - St. Christopher's Hospital for Children, Department of Pharmacy Services, 160 East Erie Avenue, Philadelphia, PA 19134 USA
Phone: +1 (215) 427-5317
Fax: +1 (215) 427-5317
Interests: pharmay paediatrics; perioperative care; medication management; health informatics
“The paediatric population is distinct from the adult population. The uniqueness of neonates, infants, children, and adolescents is beyond the physical and developmental distinctions. Consequently, drugs behave differently in [each of] these populations…paediatric patients are not simply “smaller adults….” – Preface to Pediatric Pharmacotherapy, 2013.
This is the preamble of a recent text outlining paediatric pharmacotherapy, the first of its kind in our discipline. But, the question is: What is the nature and scope of our discipline? What discipline? For over 35 years, a gifted clinician-scientist, Milap Nahata, has pleaded with us for answers to these questions, forwarding answers—many answers—so unique and compelling, that we could not turn our attention elsewhere for very long. Both Sandra and I know this man, foremost, as a mentor and teacher, but also as a friend and humanitarian, a real learner’s learner. I met him in 1977 after he finished his residency and fellowship in Buffalo, NY; Sandra being one of his many fellows, in 2002. She and I span the entirety of his professional life and brilliant career in service to pharmacy and to children.
There are people that know Milap Nahata and those that have yet to meet him. But, knowing him doesn’t matter to Dr. Nahata as no one is a stranger to him. His generosity and strength of spirit, especially for children’s issues and pharmacy’s role in such issues, is unmatched anywhere. This Special Issue is dedicated to him, to honour his profound influence on the lives of children worldwide, as well as the kindness and patience he showed his mentees, Sandra and I.
We are very grateful to have been chosen to edit this Special Issue devoted to the pharmacotherapy and medication management of children. Together as editors, with the contribution of other authors devoted to improving care for children, we will bring new ideas for your consideration, questioning even some practices we perform as paediatrically-inclined pharmacotherapists.
We hope that you will enjoy, and learn, from this Special Issue, Pharmacy Paediatrics.
Dr. Sandra Benavides Caballero
Dr. Richard Parrish
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- medication safety
- clinical pharmacy
- extemporaneous formulations
- health promotion
- medication adherence